18 October 2023

Celtarys expands its catalogue of receptor ligands with the first commercially available red-emitting fluorescent σ1/σ2 ligands

Sigma (σ) receptor subtypes, σ1 and σ2, are targets of wide pharmaceutical interest. σ1 receptor ligands are under evaluation in clinical trials for the treatment of diseases such as […]
11 September 2023

Celtarys and G.CLIPS join forces to revolutionize transmembrane proteins characterization in drug discovery. 

A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions […]
19 July 2023

Celtarys extends its chemical conjugation technology to the development of new fluorescent ligands for E3 Ubiquitin ligases

Traditional pharmacological mechanisms leave a significant part of the genome ‘undruggable’, due to the inability to induce or block their activity using agonists and antagonists. Thanks […]
13 July 2023

CELTARY & NANOTEMPER-Discovery partnership to enhance performance in GPCR characterization

Celtarys expands its presence in the GPCR field, developing new applications in collaboration agreement with Nanotemper, a company devoted to the development of innovative instruments for […]
10 July 2023

Transform your biosensor into an innovative technology

The fabrication of a particular device depends heavily on the immobilization of the biosensing element (a probe such as an antibody, aptamer, etc.) onto the transducer […]
7 July 2023

Discover Our New Fluorescent Ligands For AT1

Our portfolio of #GPCR#fluorescent ligands is growing.We have just added to our catalogue more fluorescent ligands for the AT1 receptor, CELT-145 and CELT-252. The Angiotensin AT1 receptor belongs to the […]
27 March 2023

New article showcasing Celtarys  fluorescent ligand for Dopamine D3 Receptor in Fluorescence based HTS

Celtarys Research collaborates with several research groups in Europe for the validation of our products in different assays commonly used in drug discovery, always with the […]
7 March 2023

Game Changer in Target-Based Drug Discovery  

A different way to monitor GPCR binding, target engagement and internalization with a new fluorescent-conjugate toolbox.     The past decade has witnessed fluorescently tagged drug molecules gaining […]
3 March 2023

Discover Our New Fluorescent Ligands For C5a Receptor

Our portfolio of #GPCR#fluorescent ligands is growingWe have just added to our catalogue more fluorescent ligands for the C5a receptor, CELT-58 and CELT-68. The C5a anaphylatoxin chemotactic receptor 1 (C5aR, also […]